New recycling bins are being dropped off at Rush Township residents’ properties. “With the new contract, Tamaqua Transfer had to provide the bins,” township Supervisor Robert Leibensperger said. The ...

As GLP-1s grow in popularity, more Americans are rethinking weight loss in the new year KIRKLAND, Wash, Dec. 19, 2025 /PRNewswire/ -- A new survey from Sunlight.com finds that interest in GLP-1 ...

Joey is a writer/editor, TV/radio personality, lifestyle expert, former entertainment publicist and author of "Basic Bitchen." His written work has been featured in major food and travel outlets, and ...

KIRKLAND, Wash, Dec. 19, 2025 /PRNewswire/ -- A new survey from Sunlight.com finds that interest in GLP-1 medications is rising as Americans set weight-loss goals for 2026. The December 2025 survey of ...

Illustration courtesy of Vivian Chang This 3-part series looks at the current evidence for the treatment of SUDs. Part 3 reviews the use of GLP-1 receptor agonists and tobacco use. A variety of ...

FREDONIA, N.Y. — Public works employees in the Village of Fredonia are accusing their former boss of using taxpayer-funded equipment and labor to benefit his private company. Department of Public ...

Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics. Doctors performing certain medical scans on ...

Globally, more than 1 billion people currently live with obesity. The World Health Organization on Monday released new guidance on GLP-1 medications for adults with obesity, recommending their ...

Having a baby isn't all cuddles and coos. The postpartum period is marked by sleepless nights, upturned schedules, hormone shifts – and sometimes severe depression and anxiety. Adding to all that is ...

Telehealth companies are promoting GLP-1 medications such as Ozempic and Wegovy for cosmetic weight loss in non-obese patients, despite FDA limitations on their approved use, according to a Nov. 24 ...

Illustration courtesy of Vivian Chang GLP-1 receptor agonists are being studied as a treatment for a variety of substance use disorders (SUDs). This 3-part series looks at the current evidence for the ...